when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Oncology · news · pharmadog

← back to Oncology

News · Oncology

1,498 stories

Aug 21, 26STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and morestat

Aug 21, 26STAT+: Are cancer patients getting too much drug?stat

Aug 21, 26Scientists deploy Merck’s Ebola vaccine in DRCstat

Aug 21, 26As Trump 2.0 targets federal research, a new study shows the stakesendpoints

Aug 21, 26Opinion: A cure for HIV would be a triumph. But it shouldn’t harm survivorsstat

Aug 21, 26Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?stat

Aug 20, 26Regeneron to challenge Ipsen as FDA clears bone disease drugbiopharma dive

Aug 20, 26Cancer vaccine win restores Wall Street’s faith in Modernabiopharma dive

Aug 20, 26Chutes & Ladders—Neumora shuffles leadership ahead of INDfiercebiotech

Aug 20, 26STAT+: FDA approves Ultragenyx gene therapystat

Aug 20, 26Contrasting legal decisions on gender-affirming carestat

Aug 20, 26STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and morestat

Aug 20, 26Merck’s Moderna-partnered vaccine success clears view of post-Keytruda futurebiospace

Aug 20, 26STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejectionstat

Aug 20, 26STAT+: One of the most consequential years for cancer treatment, everstat

Aug 20, 26Merck-Moderna cancer vaccine win spurs stock jump, speculation of Keytruda-like impactfiercebiotech

Aug 20, 26Why Pheast’s CEO has no regrets about transparent approach to R&D despite competitors circlingfiercebiotech

Aug 20, 26Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a studystat

Aug 20, 26STAT+: How health systems are embracing chatbots to query and summarize patient recordsstat

Aug 20, 26Why pediatric rare oncology outperforms in a volatile biotech marketbiospace

Aug 19, 26Trump's FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: Analystsbiospace

Aug 19, 26For Moderna, cancer vaccine results ease investor skepticism on its future as stock soarsendpoints

Aug 19, 26Amgen abandoning $500M+ Crohn’s collab won’t derail TScan’s pipeline strategyfiercebiotech

Aug 19, 26STAT+: Experts scrutinize Huidagene’s disclosures after patient deathstat

Aug 19, 26STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approvalstat

Aug 19, 26Trump nominates policy aide Overton to lead FDAbiopharma dive

Aug 19, 26STAT+: American Cancer Society cancels alcohol industry fundraiserstat

Aug 19, 26STAT+: Brain organoids, kept alive more than five years, matured like human brainsstat

Aug 19, 2611 companies hiring in New Jerseybiospace

Aug 19, 26Moderna stock nearly doubles as Merck-partnered mRNA cancer vaccine meets Phase 3 goalbiospace

← prevpage 20 of 50next →